Hussman Strategic Advisors’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-42,000
Closed -$239K 248
2024
Q3
$239K Hold
42,000
0.06% 183
2024
Q2
$194K Buy
+42,000
New +$194K 0.05% 203